We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
Thomas Engstrøm, MD joins Scientific Advisory Board
The management of ResoTher Pharma is pleased to announce that [...]
Kirsten Drejer joins Board of Directors
Jeppe Øvlesen, Chairman of ResoTher Pharma, is pleased to announce [...]
ResoTher Pharma closes seed round
ResoTher Pharma is pleased to announce the signing of its [...]
Latest News
Thomas Engstrøm, MD joins Scientific Advisory Board
The management of ResoTher Pharma is pleased to announce that [...]
Kirsten Drejer joins Board of Directors
Jeppe Øvlesen, Chairman of ResoTher Pharma, is pleased to announce [...]
ResoTher Pharma closes seed round
ResoTher Pharma is pleased to announce the signing of its [...]
